Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam 6 months versus 12 months after glioma surgery for glioma-related epilepsy
ChiCTR2000030228Phase 4Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levetiracetam in epilepsy and glioma (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Engel outcome classification. Planned start May 2020; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsyglioma
Beyond the preview
Go deeper on ChiCTR2000030228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030228.